Poster Presentations

被引:0
作者
F. Clerici
S. Spila-Alegiani
A. Elia
N. Vanacore
R. Da Cas
R. Raschetti
C. Mariani
机构
[1] University of Milan,Centre for Research and Treatment on Cognitive Dysfunctions, Institute of Clinical Neurology, “Luigi Sacco” Hospital
[2] National Centre for Epidemiology,undefined
[3] Surveillance and Health Promotion,undefined
[4] National Institute of Health,undefined
关键词
Adverse Drug Reaction; Alzheimer Disease; Cholinesterase; Acetyl Cholinesterase; Memantine;
D O I
10.2165/00002018-200730100-00102
中图分类号
学科分类号
摘要
引用
收藏
页码:1011 / 1011
相关论文
共 11 条
[1]  
Reisberg B(2003)Memantine in moderate-to-severe Alzheimer disease N Eng J Med 348 1333-41
[2]  
Doody R(2004)Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donezepil: a randomized controlled trial JAMA 291 317-24
[3]  
Stoffler A(2000)A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist Memantine Pharmacopsychiatry 33 103-8
[4]  
Tariot PN(2003)Tolerability of nemantine in combination with cholinesterase inhibitors in dementia therapy Int Clin Psychopharmacology 18 81-5
[5]  
Flarlow MR(undefined)undefined undefined undefined undefined-undefined
[6]  
Grossberg G(undefined)undefined undefined undefined undefined-undefined
[7]  
Ruther E(undefined)undefined undefined undefined undefined-undefined
[8]  
Glaser A(undefined)undefined undefined undefined undefined-undefined
[9]  
Bleich S(undefined)undefined undefined undefined undefined-undefined
[10]  
Hartmann S(undefined)undefined undefined undefined undefined-undefined